Free Trial

ViewRay (VRAYQ) Competitors

VRAYQ vs. TTOO, SDCCQ, GMVDF, AFIB, SONX, NMRD, UTRS, MOTS, VIVE, and DRTSW

Should you be buying ViewRay stock or one of its competitors? The main competitors of ViewRay include T2 Biosystems (TTOO), SmileDirectClub (SDCCQ), G Medical Innovations (GMVDF), Acutus Medical (AFIB), Sonendo (SONX), Nemaura Medical (NMRD), Minerva Surgical (UTRS), Motus GI (MOTS), Viveve Medical (VIVE), and Alpha Tau Medical (DRTSW). These companies are all part of the "medical equipment" industry.

ViewRay vs. Its Competitors

T2 Biosystems (NASDAQ:TTOO) and ViewRay (NASDAQ:VRAYQ) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, media sentiment, profitability and analyst recommendations.

23.2% of T2 Biosystems shares are owned by institutional investors. Comparatively, 15.5% of ViewRay shares are owned by institutional investors. 0.0% of T2 Biosystems shares are owned by insiders. Comparatively, 2.5% of ViewRay shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

T2 Biosystems has higher earnings, but lower revenue than ViewRay.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
T2 Biosystems$7.68M0.03-$50.08MN/AN/A
ViewRay$102.21M0.00-$107.33MN/AN/A

ViewRay has a net margin of 0.00% compared to T2 Biosystems' net margin of -563.16%.

Company Net Margins Return on Equity Return on Assets
T2 Biosystems-563.16% N/A -174.06%
ViewRay N/A N/A N/A

In the previous week, T2 Biosystems' average media sentiment score of 0.00 equaled ViewRay'saverage media sentiment score.

Company Overall Sentiment
T2 Biosystems Neutral
ViewRay Neutral

T2 Biosystems has a beta of 0.19, suggesting that its stock price is 81% less volatile than the S&P 500. Comparatively, ViewRay has a beta of 1.05, suggesting that its stock price is 5% more volatile than the S&P 500.

Summary

ViewRay beats T2 Biosystems on 5 of the 7 factors compared between the two stocks.

Get ViewRay News Delivered to You Automatically

Sign up to receive the latest news and ratings for VRAYQ and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VRAYQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VRAYQ vs. The Competition

MetricViewRayElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$18K$41.15M$5.76B$9.85B
Dividend YieldN/AN/A6.67%4.51%
P/E RatioN/A3.7075.7126.43
Price / SalesN/A209.60548.17119.09
Price / CashN/A41.3637.0558.92
Price / BookN/A2.7111.296.06
Net Income-$107.33M-$2.66M$3.29B$266.28M

ViewRay Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VRAYQ
ViewRay
N/AN/AN/AN/A$18K$102.21M0.00300Gap Up
TTOO
T2 Biosystems
N/A$0.00
+27.3%
N/A-99.6%$59K$7.68M0.00180Gap Down
SDCCQ
SmileDirectClub
N/A$0.00
-50.0%
N/AN/A$40K$470.74M0.002,700Gap Down
GMVDF
G Medical Innovations
N/A$0.00
flat
N/AN/A$26K$4.42M0.0072
AFIB
Acutus Medical
N/A$0.00
flat
N/A-98.9%$15K$7.16M0.00340Gap Down
SONX
Sonendo
N/A$0.03
flat
N/A-37.0%$13K$44.40M0.00250
NMRD
Nemaura Medical
0.9269 of 5 stars
$0.00
flat
N/AN/A$4K$3.02K0.0040
UTRS
Minerva Surgical
N/AN/AN/AN/A$1K$51.69M0.00160
MOTS
Motus GI
0.0867 of 5 stars
N/AN/AN/A$1K$319K0.0030Gap Down
VIVE
Viveve Medical
N/A$0.00
flat
N/AN/A$1K$6.83M0.0070High Trading Volume
DRTSW
Alpha Tau Medical
N/A$0.30
+1.7%
N/A+30.9%$0.00N/A0.0080

Related Companies and Tools


This page (NASDAQ:VRAYQ) was last updated on 9/5/2025 by MarketBeat.com Staff
From Our Partners